Oxymetazoline

CHEMBL762 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

260.4 g/mol

LogP

2.9

Phase

4

A nasal decongestant providing up to 12 hours of congestion relief, limited to 3 days to avoid rebound.

Masse moléculaire

260,3700 g/mol

LogP

2,90

TPSA

44,60 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Pancreatic Cancer Cardiovascular Disease Pain Management Ophthalmology Rheumatoid Arthritis Asthma Chronic Obstructive Pulmonary Disease Alzheimer's Disease Parkinson's Disease Epilepsy Migraine Schizophrenia Insomnia Gastroesophageal Reflux Disease Inflammatory Bowel Disease Psoriasis Systemic Lupus Erythematosus Multiple Sclerosis Chronic Kidney Disease Stroke Deep Vein Thrombosis / Pulmonary Embolism Obesity Type 2 Diabetes Hypertension Breast Cancer Gout Chronic Pain Heart Failure Atrial Fibrillation

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1

InChI

InChI=1S/C16H24N2O/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14/h8,19H,6-7,9H2,1-5H3,(H,17,18)

Molecular Formula

C16H24N2O

HBD / HBA

2 / 2

Liaisons Rotatives

3

Atomes Lourds

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A nasal decongestant providing up to 12 hours of congestion relief, limited to 3 days to avoid rebound.

Yes, Oxymetazoline is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL762. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4636. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Oxymetazoline sur PillFYI

Structure

Données Clés

Formule: C16H24N2O
Synonymes: 172

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.